Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Neoplasms 2Smoking 1Pulmonary Disease, Chronic Obstructive 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ototoxicity 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Hyperlipoproteinemia Type II 1Hematologic Neoplasms 1Hemangioma, Cavernous, Central Nervous System 1Hearing Loss 1Head and Neck Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colorectal Neoplasms 1Colitis, Ulcerative 1Cardiotoxicity 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1

Interventions

sodium thiosulfate 1ebselen 1Vorinostat 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Hearing Tests 1Genetic Association Studies 1Cisplatin 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ototoxicity × Atorvastatin × 1 year × Clear all
NCT06553157 2026-01-20

Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy

Minia University

Phase 1/2 Completed
56 enrolled

Ototoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡